Search Results - "Mooi, J.K."

The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial by Mooi, J.K., Wirapati, P., Asher, R., Lee, C.K., Savas, P., Price, T.J., Townsend, A., Hardingham, J., Buchanan, D., Williams, D., Tejpar, S., Mariadason, J.M., Tebbutt, N.C.

“…The consensus molecular subtypes (CMS) is a transcriptome-based classification of colorectal cancer (CRC) initially described in early-stage cohorts, but the…”
Get full text

Teleoncology for Indigenous patients: The responses of patients and health workers by Mooi, Jennifer K, Whop, Lisa J, Valery, Patricia C, Sabesan, Sabe S

“…Problem: Townsville Cancer Centre provides video‐consultation (VC) services to patients in rural/remote regions of North Queensland in order to improve access…”
Get full text